Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins

Clinical trial NCT02974244 · COMPLETED

Trial details

NCT number: NCT02974244
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes

Start date: 2014-10-28
Primary completion: 2014-10-28
Enrollment: 7000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.